Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis

Veronique Belzil, Jean Sébastien Langlais, Hussein Daoud, Patrick A. Dion, Bernard Brais, Guy A. Rouleau

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Juvenile amyotrophic lateral sclerosis (JALS) refers to a form of amyotrophic lateral sclerosis (ALS) in which a progressive upper and lower motor neuron degeneration begins before 25 years of age. It is generally associated with slow disease progression. During the past decade, a number of genes have been reported to cause JALS. Mutations in the ALSIN gene cause JALS type 2 (ALS2) as well as juvenile primary lateral sclerosis and infantileonset ascending spastic paralysis. Mutations in the SETX gene can also sometimes lead to JALS. Conversely, mutations in SOD1, TARDBP, and FUS typically cause pure ALS, with adult onset between 46 and 56 years of age and usually rapid progression over 3 to 5 years. Recently, a few mutations in FUS have been associated with juvenile-onset of ALS characterized by a very rapid progression. Objective: To investigate the genetics of a patient with juvenile-onset ALS. Design and Patient: We sequenced all the coding exons of SOD1, TARDBP, and FUS in a 19-year-old patient experiencing rapid degeneration of upper and lower motor neurons. Results: A novel 1-base pair deletion was detected in exon 14 of the FUS gene, leading to a frameshift and the integration of 33 new amino acids. The variant p.R495QfsX527 is located in the highly conserved, extreme C terminal of the FUS protein, where most of the mutations in FUS have been identified. The variant was also identified in the unaffected 47-year-old mother of the patient, who remains asymptomatic. Conclusions: Our finding, along with other research, further confirms that FUS mutations can lead to an earlyonset malignant form of ALS. In addition, our data lend additional support to the notion that disruption of the conservedCterminal of FUS is critical for developing ALS.

Original languageEnglish (US)
Pages (from-to)653-656
Number of pages4
JournalArchives of neurology
Volume69
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Amyotrophic Lateral Sclerosis
Mutation
Motor Neurons
Genes
RNA-Binding Protein FUS
Exons
Nerve Degeneration
Muscle Spasticity
Base Pairing
Paralysis
Disease Progression
Mothers
Amino Acids
Gene

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis. / Belzil, Veronique; Langlais, Jean Sébastien; Daoud, Hussein; Dion, Patrick A.; Brais, Bernard; Rouleau, Guy A.

In: Archives of neurology, Vol. 69, No. 5, 01.05.2012, p. 653-656.

Research output: Contribution to journalArticle

Belzil, V, Langlais, JS, Daoud, H, Dion, PA, Brais, B & Rouleau, GA 2012, 'Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis', Archives of neurology, vol. 69, no. 5, pp. 653-656. https://doi.org/10.1001/archneurol.2011.2499
Belzil, Veronique ; Langlais, Jean Sébastien ; Daoud, Hussein ; Dion, Patrick A. ; Brais, Bernard ; Rouleau, Guy A. / Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis. In: Archives of neurology. 2012 ; Vol. 69, No. 5. pp. 653-656.
@article{38500252823e474da288155ec81a6c63,
title = "Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis",
abstract = "Background: Juvenile amyotrophic lateral sclerosis (JALS) refers to a form of amyotrophic lateral sclerosis (ALS) in which a progressive upper and lower motor neuron degeneration begins before 25 years of age. It is generally associated with slow disease progression. During the past decade, a number of genes have been reported to cause JALS. Mutations in the ALSIN gene cause JALS type 2 (ALS2) as well as juvenile primary lateral sclerosis and infantileonset ascending spastic paralysis. Mutations in the SETX gene can also sometimes lead to JALS. Conversely, mutations in SOD1, TARDBP, and FUS typically cause pure ALS, with adult onset between 46 and 56 years of age and usually rapid progression over 3 to 5 years. Recently, a few mutations in FUS have been associated with juvenile-onset of ALS characterized by a very rapid progression. Objective: To investigate the genetics of a patient with juvenile-onset ALS. Design and Patient: We sequenced all the coding exons of SOD1, TARDBP, and FUS in a 19-year-old patient experiencing rapid degeneration of upper and lower motor neurons. Results: A novel 1-base pair deletion was detected in exon 14 of the FUS gene, leading to a frameshift and the integration of 33 new amino acids. The variant p.R495QfsX527 is located in the highly conserved, extreme C terminal of the FUS protein, where most of the mutations in FUS have been identified. The variant was also identified in the unaffected 47-year-old mother of the patient, who remains asymptomatic. Conclusions: Our finding, along with other research, further confirms that FUS mutations can lead to an earlyonset malignant form of ALS. In addition, our data lend additional support to the notion that disruption of the conservedCterminal of FUS is critical for developing ALS.",
author = "Veronique Belzil and Langlais, {Jean S{\'e}bastien} and Hussein Daoud and Dion, {Patrick A.} and Bernard Brais and Rouleau, {Guy A.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1001/archneurol.2011.2499",
language = "English (US)",
volume = "69",
pages = "653--656",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis

AU - Belzil, Veronique

AU - Langlais, Jean Sébastien

AU - Daoud, Hussein

AU - Dion, Patrick A.

AU - Brais, Bernard

AU - Rouleau, Guy A.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Background: Juvenile amyotrophic lateral sclerosis (JALS) refers to a form of amyotrophic lateral sclerosis (ALS) in which a progressive upper and lower motor neuron degeneration begins before 25 years of age. It is generally associated with slow disease progression. During the past decade, a number of genes have been reported to cause JALS. Mutations in the ALSIN gene cause JALS type 2 (ALS2) as well as juvenile primary lateral sclerosis and infantileonset ascending spastic paralysis. Mutations in the SETX gene can also sometimes lead to JALS. Conversely, mutations in SOD1, TARDBP, and FUS typically cause pure ALS, with adult onset between 46 and 56 years of age and usually rapid progression over 3 to 5 years. Recently, a few mutations in FUS have been associated with juvenile-onset of ALS characterized by a very rapid progression. Objective: To investigate the genetics of a patient with juvenile-onset ALS. Design and Patient: We sequenced all the coding exons of SOD1, TARDBP, and FUS in a 19-year-old patient experiencing rapid degeneration of upper and lower motor neurons. Results: A novel 1-base pair deletion was detected in exon 14 of the FUS gene, leading to a frameshift and the integration of 33 new amino acids. The variant p.R495QfsX527 is located in the highly conserved, extreme C terminal of the FUS protein, where most of the mutations in FUS have been identified. The variant was also identified in the unaffected 47-year-old mother of the patient, who remains asymptomatic. Conclusions: Our finding, along with other research, further confirms that FUS mutations can lead to an earlyonset malignant form of ALS. In addition, our data lend additional support to the notion that disruption of the conservedCterminal of FUS is critical for developing ALS.

AB - Background: Juvenile amyotrophic lateral sclerosis (JALS) refers to a form of amyotrophic lateral sclerosis (ALS) in which a progressive upper and lower motor neuron degeneration begins before 25 years of age. It is generally associated with slow disease progression. During the past decade, a number of genes have been reported to cause JALS. Mutations in the ALSIN gene cause JALS type 2 (ALS2) as well as juvenile primary lateral sclerosis and infantileonset ascending spastic paralysis. Mutations in the SETX gene can also sometimes lead to JALS. Conversely, mutations in SOD1, TARDBP, and FUS typically cause pure ALS, with adult onset between 46 and 56 years of age and usually rapid progression over 3 to 5 years. Recently, a few mutations in FUS have been associated with juvenile-onset of ALS characterized by a very rapid progression. Objective: To investigate the genetics of a patient with juvenile-onset ALS. Design and Patient: We sequenced all the coding exons of SOD1, TARDBP, and FUS in a 19-year-old patient experiencing rapid degeneration of upper and lower motor neurons. Results: A novel 1-base pair deletion was detected in exon 14 of the FUS gene, leading to a frameshift and the integration of 33 new amino acids. The variant p.R495QfsX527 is located in the highly conserved, extreme C terminal of the FUS protein, where most of the mutations in FUS have been identified. The variant was also identified in the unaffected 47-year-old mother of the patient, who remains asymptomatic. Conclusions: Our finding, along with other research, further confirms that FUS mutations can lead to an earlyonset malignant form of ALS. In addition, our data lend additional support to the notion that disruption of the conservedCterminal of FUS is critical for developing ALS.

UR - http://www.scopus.com/inward/record.url?scp=84860904002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860904002&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2011.2499

DO - 10.1001/archneurol.2011.2499

M3 - Article

C2 - 22248478

AN - SCOPUS:84860904002

VL - 69

SP - 653

EP - 656

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 5

ER -